Table 1.
Baseline characteristics.
| Characteristics | LVEDD | ||||||
| Overall | Q1 | Q2 | Q3 | Q4 | p-value | ||
| (N = 33,147) | (N = 7564) | (N = 7169) | (N = 9840) | (N = 8574) | |||
| Demographic | |||||||
| Age, years | 62.95 (10.61) | 64.78 (10.26) | 62.89 (10.48) | 62.07 (10.73) | 62.39 (10.68) | 0.001 | |
| Age 75, n (%) | 4794 (14.46) | 1359 (17.97) | 1004 (14.00) | 1273 (12.94) | 1158 (13.51) | 0.001 | |
| Female, n (%) | 7959 (24.01) | 2993 (39.57) | 1869 (26.07) | 1919 (19.50) | 1178 (13.74) | 0.001 | |
| Medical history | |||||||
| AMI, n (%) | 6708 (20.24) | 977 (12.92) | 1269 (17.71) | 2391 (24.31) | 2071 (24.16) | 0.001 | |
| HT, n (%) | 18,668 (56.34) | 4308 (56.98) | 4066 (56.75) | 5588 (56.81) | 4706 (54.89) | 0.019 | |
| DM, n (%) | 9000 (27.16) | 1949 (25.78) | 1859 (25.95) | 2628 (26.72) | 2564 (29.91) | 0.001 | |
| CKD, n (%) | 5934 (22.03) | 1159 (19.32) | 1008 (17.46) | 1533 (19.29) | 2234 (30.95) | 0.001 | |
| CHF, n (%) | 3390 (10.24) | 427 (5.65) | 461 (6.44) | 784 (7.98) | 1718 (20.04) | 0.001 | |
| PCI, n (%) | 23,824 (71.87) | 5240 (69.28) | 5192 (72.42) | 7288 (74.07) | 6104 (71.19) | 0.001 | |
| Anemia, n (%) | 10,554 (33.10) | 2154 (29.51) | 2057 (29.88) | 3088 (32.76) | 3255 (39.35) | 0.001 | |
| AF, n (%) | 1109 (3.35) | 237 (3.13) | 185 (2.58) | 279 (2.84) | 408 (4.76) | 0.001 | |
| Laboratory test | |||||||
| GLU, mmol/L | 7.11 (3.29) | 6.97 (3.26) | 7.00 (3.21) | 7.04 (3.18) | 7.40 (3.50) | 0.001 | |
| HbA1c, % | 6.55 (1.42) | 6.52 (1.40) | 6.53 (1.44) | 6.51 (1.39) | 6.64 (1.46) | 0.001 | |
| LDL-C, mmol/L | 2.83 (0.98) | 2.85 (0.98) | 2.84 (0.97) | 2.82 (0.96) | 2.82 (1.00) | 0.116 | |
| HDL-C, mmol/L | 1.00 (0.26) | 1.05 (0.27) | 1.01 (0.26) | 0.98 (0.25) | 0.95 (0.25) | 0.001 | |
| HGB, g/L | 132.83 (17.04) | 132.69 (15.79) | 134.02 (16.26) | 133.37 (16.87) | 131.33 (18.74) | 0.001 | |
| eGFR, mL/min/1.73 m2 | 77.17 (25.24) | 79.02 (25.97) | 80.21 (23.73) | 78.89 (24.30) | 71.33 (25.87) | 0.001 | |
| Echocardiography | |||||||
| LVEDD, mm | 48.49 (6.90) | 40.99 (2.04) | 45.03 (0.81) | 48.74 (1.38) | 57.70 (5.72) | 0.001 | |
| LVESD, mm | 32.11 (8.43) | 28.06 (3.01) | 25.23 (2.91) | 31.23 (3.90) | 42.56 (8.75) | 0.001 | |
| LVPWT, mm | 9.92 (1.80) | 9.99 (1.85) | 9.86 (1.55) | 10.06 (1.87) | 9.75 (1.89) | 0.001 | |
| LVEF, % | 58.91 (12.10) | 65.05 (6.94) | 63.60 (7.84) | 60.87 (9.30) | 47.37 (13.54) | 0.001 | |
| Medication | |||||||
| ACEI/ARB, n (%) | 16,436 (50.34) | 3520 (47.15) | 3518 (49.69) | 5025 (51.75) | 4373 (52.11) | 0.001 | |
| Beta-blockers, n (%) | 26,584 (81.42) | 5976 (80.04) | 5734 (80.99) | 7976 (82.13) | 6898 (82.20) | 0.001 | |
| Statins, n (%) | 30,791 (94.31) | 7070 (94.70) | 6711 (94.79) | 9223 (94.97) | 7787 (92.79) | 0.001 | |
Abbreviation: ACEI/ARB, angiotensin converting enzyme inhibitor/angiotensin receptor blocker; AF, atrial fibrillation; AMI, acute myocardial infarction; CHF, congestive heart failure; CKD, chronic kidney disease; DM, diabetes; eGFR, estimated glomerular filtration rate; GLU, glucose; HbA1c, hemoglobin A1c; HDL-C, high-density lipoprotein cholesterol; HGB, hemoglobin; HT, hypertension; LDL-C, low-density lipoprotein cholesterol; LVEDD, left ventricular end-diastolic dimension; LVEF, left ventricular ejection fraction; LVESD, left ventricular end-systolic dimension; LVPWT, left ventricular posterior wall thickness; PCI, percutaneous coronary intervention.
Q1, Quartile 1; Q2, Quartile 2; Q3, Quartile 3; Q4, Quartile 4.